Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
Journal of Natural Medicines
|
August 18, 2016
Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness
Shuso Takeda, Taichi Himeno, Kazuhiro Kakizoe, et al.
The Journal of Toxicological Sciences
|
November 13, 2015
Cannabidiol-2',6'-dimethyl ether stimulates body weight gain in apolipoprotein E-deficient BALB/c. KOR/Stm Slc-Apoe(shl) mice
Shuso Takeda, Rena Hirota, Sari Teradaira, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 9, 2006
Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode
Shuso Takeda, Yurie Kitajima, Yuji Ishii, et al.
Biological & Pharmaceutical Bulletin
|
October 6, 2005
Modulation of UDP-glucuronosyltransferase 2B7 function by cytochrome P450s in vitro: differential effects of CYP1A2, CYP2C9 and CYP3A4
Shuso Takeda, Yuji Ishii, Peter I Mackenzie, et al.
The Journal of Toxicological Sciences
|
September 7, 2018
Cadmium down-regulates apolipoprotein E (ApoE) expression during malignant transformation of rat liver cells: direct evidence for DNA hypermethylation in the promoter region of ApoE
Masayo Hirao-Suzuki, Shuso Takeda, Takanobu Kobayashi, et al.
Life Sciences
|
February 13, 2007
Suppression of fetal testicular cytochrome P450 17 by maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: a mechanism involving an initial effect on gonadotropin synthesis in the pituitary
Junko Taketoh, Junpei Mutoh, Tomoki Takeda, et al.
Anticancer Research
|
November 1, 2016
Bongkrekic Acid as a Warburg Effect Modulator in Long-term Estradiol-deprived MCF-7 Breast Cancer Cells
Shuso Takeda, Hiroyuki Okazaki, Taichi Kudo, et al.
Journal of Pharmaceutical Sciences
|
October 5, 2010
Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors
Shuso Takeda, Rongrong Jiang, Hironori Aramaki, et al.
Toxicology and Applied Pharmacology
|
May 12, 2005
2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced change in intestinal function and pathology: evidence for the involvement of arylhydrocarbon receptor-mediated alteration of glucose transportation
Takumi Ishida, Shoko Kan-o, Junpei Mutoh, et al.
Molecular Pharmacology
|
December 22, 2004
Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4
Shuso Takeda, Yuji Ishii, Megumi Iwanaga, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
Journal of Natural Medicines
|
August 18, 2016
Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness
Shuso Takeda, Taichi Himeno, Kazuhiro Kakizoe, et al.
The Journal of Toxicological Sciences
|
November 13, 2015
Cannabidiol-2',6'-dimethyl ether stimulates body weight gain in apolipoprotein E-deficient BALB/c. KOR/Stm Slc-Apoe(shl) mice
Shuso Takeda, Rena Hirota, Sari Teradaira, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 9, 2006
Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode
Shuso Takeda, Yurie Kitajima, Yuji Ishii, et al.
Biological & Pharmaceutical Bulletin
|
October 6, 2005
Modulation of UDP-glucuronosyltransferase 2B7 function by cytochrome P450s in vitro: differential effects of CYP1A2, CYP2C9 and CYP3A4
Shuso Takeda, Yuji Ishii, Peter I Mackenzie, et al.
The Journal of Toxicological Sciences
|
September 7, 2018
Cadmium down-regulates apolipoprotein E (ApoE) expression during malignant transformation of rat liver cells: direct evidence for DNA hypermethylation in the promoter region of ApoE
Masayo Hirao-Suzuki, Shuso Takeda, Takanobu Kobayashi, et al.
Life Sciences
|
February 13, 2007
Suppression of fetal testicular cytochrome P450 17 by maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: a mechanism involving an initial effect on gonadotropin synthesis in the pituitary
Junko Taketoh, Junpei Mutoh, Tomoki Takeda, et al.
Anticancer Research
|
November 1, 2016
Bongkrekic Acid as a Warburg Effect Modulator in Long-term Estradiol-deprived MCF-7 Breast Cancer Cells
Shuso Takeda, Hiroyuki Okazaki, Taichi Kudo, et al.
Journal of Pharmaceutical Sciences
|
October 5, 2010
Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors
Shuso Takeda, Rongrong Jiang, Hironori Aramaki, et al.
Toxicology and Applied Pharmacology
|
May 12, 2005
2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced change in intestinal function and pathology: evidence for the involvement of arylhydrocarbon receptor-mediated alteration of glucose transportation
Takumi Ishida, Shoko Kan-o, Junpei Mutoh, et al.
Molecular Pharmacology
|
December 22, 2004
Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4
Shuso Takeda, Yuji Ishii, Megumi Iwanaga, et al.
Page
of 7